Samuel Cykert

Samuel Cykert

Auto-generated profile, based on publicly available information

Samuel Cykert

Division of General Medicine and Clinical Epidemiology, University of North Carolina School of Medicine, Chapel Hill, USA

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 June 2010 in JAMA
Verified
Journal Article
Open access
PDF file
SCSamuel Cykert
Samuel Cykert
PDPeggye Dilworth-Anderson
Peggye Dilworth-Anderson
MMMichael H. Monroe
Michael H. Monroe
PWPaul Walker
Paul Walker
FMFranklin R. McGuire
Franklin R. McGuire
ABAudrina Jones Bunton
Audrina Jones Bunton
Lung cancer remains the leading cause of cancer death in the United States and proportionally this burden is greater for blacks.1 Non–small cell histology represents more than 80% of cases.2,3 Quiz Ref ID Surgical resection for stage I or II disease remains the only reliable cure.4 Patients who do not undergo appropriate surgery face a median survival of less than 1 year and the sequelae of progressive cancer and then death; while those who undergo appropriate surgery have a median survival of more than 4 years.5-7 Despite patients' fear of cancer8 and the dismal outcomes for those who do not proceed to surgery, administrative data5,9 consistently show that almost one-third of patients with potentially curable disease do not undergo resection surgery. A persistent surgical gap that disadvantages black patients has been reported for more than a decade.10-12

1 June 2000 in Chest
Verified
Journal Article
Closed access
PDF file
SCSamuel Cykert
Samuel Cykert
GKGrace Kissling
Grace Kissling
CHCharles J. Hansen
Charles J. Hansen

4 February 2019 in Cancer Medicine
Verified
Journal Article
Open access
PDF file
SCSamuel Cykert
Samuel Cykert
EEEugenia Eng
Eugenia Eng
PWPaul Walker
Paul Walker
MMMatthew A. Manning
Matthew A. Manning
LRLinda B. Robertson
Linda B. Robertson
DHDwight E. Heron
Dwight E. Heron
Background: Advances in early diagnosis and curative treatment have reduced high mortality rates associated with non‐small cell lung cancer. However, racial disparity in survival persists partly because Black patients receive less curative treatment than White patients.Methods: We performed a 5‐year pragmatic, trial at five cancer centers using a system‐based intervention. Patients diagnosed with early stage lung cancer, aged 18‐85 were eligible. Intervention components included: (1) a real‐time warning system derived from electronic health records, (2) race‐specific feedback to clinical teams on treatment completion rates, and (3) a nurse navigator. Consented patients were compared to retrospective and concurrent controls. The primary outcome was receipt of curative treatment.Results: There were 2841 early stage lung cancer patients (16% Black) in the retrospective group and 360 (32% Black) in the intervention group. For the retrospective baseline, crude treatment rates were 78% for White patients vs 69% for Black patients (P < 0.001); difference by race was confirmed by a model adjusted for age, treatment site, cancer stage, gender, comorbid illness, and income‐odds ratio (OR) 0.66 for Black patients (95% CI 0.51‐0.85, P = 0.001). Within the intervention cohort, the crude rate was 96.5% for Black vs 95% for White patients (P = 0.56). Odds ratio for the adjusted analysis was 2.1 (95% CI 0.41‐10.4, P = 0.39) for Black vs White patients. Between group analyses confirmed treatment parity for the intervention.Conclusion: A system‐based intervention tested in five cancer centers reduced racial gaps and improved care for all.

1 October 2020 in Journal of the National Medical Association
Verified
Journal Article
Closed access
SCSamuel Cykert
Samuel Cykert
EEEugenia Eng
Eugenia Eng
MMMatthew A. Manning
Matthew A. Manning
LRLinda B. Robertson
Linda B. Robertson
DHDwight E. Heron
Dwight E. Heron
ZGZiya Gizlice
Ziya Gizlice

14 February 2022 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
MCMarjory Charlot
Marjory Charlot
JSJacob Newton Stein
Jacob Newton Stein
EDEmily Damone
Emily Damone
IWIsabella Wood
Isabella Wood
MFMoriah Forster
Moriah Forster
SCSamuel Cykert
Samuel Cykert
PURPOSE: Timely lung cancer surgery is a metric of high-quality cancer care and improves survival for early-stage non–small-cell lung cancer. Historically, Black patients experience longer delays to surgery than White patients and have lower survival rates. Antiracism interventions have shown benefits in reducing racial disparities in lung cancer treatment. METHODS: We conducted a secondary analysis of Accountability for Cancer Care through Undoing Racism and Equity, an antiracism prospective pragmatic trial, at five cancer centers to assess the impact on overall timeliness of lung cancer surgery and racial disparities in timely surgery. The intervention consisted of (1) a real-time warning system to identify unmet care milestones, (2) race-specific feedback on lung cancer treatment rates, and (3) patient navigation. The primary outcome was surgery within 8 weeks of diagnosis. Risk ratios (RRs) and 95% CIs were estimated using log-binomial regression and adjusted for clinical and demographic factors. RESULTS: A total of 2,363 patients with stage I and II non–small-cell lung cancer were included in the analyses: intervention (n = 263), retrospective control (n = 1,798), and concurrent control (n = 302). 87.1% of Black patients and 85.4% of White patients in the intervention group ( P = .13) received surgery within 8 weeks of diagnosis compared with 58.7% of Black patients and 75.0% of White patients in the retrospective group ( P < .01) and 64.9% of Black patients and 73.2% of White patients ( P = .29) in the concurrent group. Black patients in the intervention group were more likely to receive timely surgery than Black patients in the retrospective group (RR 1.43; 95% CI, 1.26 to 1.64). White patients in the intervention group also had timelier surgery than White patients in the retrospective group (RR 1.10; 95% CI, 1.02 to 1.18). CONCLUSION: Accountability for Cancer Care through Undoing Racism and Equity is associated with timelier lung cancer surgery and reduction of the racial gap in timely surgery.

16 February 2022 in Social Science & Medicine
Verified
Journal Article
Closed access
JRJennifer Richmond
Jennifer Richmond
MBMarcella H. Boynton
Marcella H. Boynton
SOSachiko Ozawa
Sachiko Ozawa
KMKathryn E. Muessig
Kathryn E. Muessig
SCSamuel Cykert
Samuel Cykert
KRKurt M. Ribisl
Kurt M. Ribisl